Nitisinone (NTBC)

DRUG2 trials

Sponsors

University of Florida, National Human Genome Research Institute (NHGRI)

Conditions

Acidosis, LacticAlkaptonuriaChronic Disease

Phase 2

Long-Term Study of Nitisinone to Treat Alkaptonuria

CompletedNCT00107783

National Human Genome Research Institute (NHGRI)Alkaptonuria

Start: 2005-01-31End: 2009-04-30Updated: 2021-08-26

Unknown Phase

Prevention of Dichloroacetate Toxicity

CompletedNCT00031161

University of FloridaAcidosis, Lactic, Chronic Disease

Start: 2001-09-30End: 2005-09-30Target: 30Updated: 2015-03-25